Literature DB >> 22514346

TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.

Rajeev K Boregowda1, Christina Adams, Jianming Hu.   

Abstract

The hepadnavirus reverse transcriptase (RT) has the unique ability to initiate viral DNA synthesis using RT itself as a protein primer. Protein priming requires complex interactions between the N-terminal TP (terminal protein) domain, where the primer (a specific Y residue) resides, and the central RT domain, which harbors the polymerase active site. While it normally utilizes the cis-linked TP to prime DNA synthesis (cis-priming), we found that the duck hepatitis B virus (DHBV) RT domain, in the context of the full-length RT protein or a mini-RT construct containing only truncated TP and RT domains, could additionally use a separate TP or RT domain in trans as a primer (trans-priming). trans interaction could also be demonstrated by the inhibitory effect (trans-inhibition) on cis-priming by TP and RT domain sequences provided in trans. Protein priming was further shown to induce RT conformational changes that resulted in TP-RT domain dissociation, altered priming site selection, and a gain of sensitivity to a pyrophosphate analog inhibitor. trans-priming, trans-inhibition, and trans-complementation, which requires separate TP and RT domains to reconstitute a functional RT protein, were employed to define the sequences in the TP and RT domains that could mediate physical or functional inter- and intradomain interactions. These results provide new insights into TP-RT domain interactions and conformational dynamics during protein priming and suggest novel means to inhibit protein priming by targeting these interactions and the associated conformational transitions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514346      PMCID: PMC3393569          DOI: 10.1128/JVI.00086-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

2.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 3.  Adenylylation: renaissance of a forgotten post-translational modification.

Authors:  Aymelt Itzen; Wulf Blankenfeldt; Roger S Goody
Journal:  Trends Biochem Sci       Date:  2011-01-20       Impact factor: 13.807

4.  Mutagenesis of a hepatitis B virus reverse transcriptase yields temperature-sensitive virus.

Authors:  C Seeger; E H Leber; L K Wiens; J Hu
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

5.  Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.

Authors:  Karl E Zahn; Egor P Tchesnokov; Matthias Götte; Sylvie Doublié
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

7.  Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase.

Authors:  R E Lanford; L Notvall; H Lee; B Beames
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding.

Authors:  Michael Stahl; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  9 in total

1.  Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.

Authors:  F Cao; S Jones; W Li; X Cheng; Y Hu; J Hu; J E Tavis
Journal:  J Viral Hepat       Date:  2014-01-09       Impact factor: 3.728

2.  Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.

Authors:  Judit Vörös; Annika Urbanek; Gilles Jean Philippe Rautureau; Maggie O'Connor; Henry C Fisher; Alison E Ashcroft; Neil Ferguson
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; John M Flanagan; Jianming Hu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 5.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

6.  Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming.

Authors:  Scott A Jones; Daniel N Clark; Feng Cao; John E Tavis; Jianming Hu
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 7.  Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention.

Authors:  Scott A Jones; Jianming Hu
Journal:  Emerg Microbes Infect       Date:  2013-09-04       Impact factor: 7.163

Review 8.  Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target.

Authors:  Timothy S Buhlig; Anastasia F Bowersox; Daniel L Braun; Desiree N Owsley; Kortney D James; Alfredo J Aranda; Connor D Kendrick; Nicole A Skalka; Daniel N Clark
Journal:  Viruses       Date:  2020-05-22       Impact factor: 5.048

9.  Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virus.

Authors:  Elin Teppa; Francesca Nadalin; Christophe Combet; Diego Javier Zea; Laurent David; Alessandra Carbone
Journal:  Virus Evol       Date:  2020-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.